From insilico to wet lab: structure-based design and synthesis of flavone derivatives targeting COX-2 and aurora kinase for anti-inflammatory and analgesic activity
Authors:
- Kalyani AsgaonkarKAKalyani Asgaonkar
- Shubham KachareSKShubham Kachare
- Kalirajan RajagopalKRKalirajan Rajagopal
- Krishna ShevateKSKrishna Shevate
- Gaurav KhaireGKGaurav Khaire
- Shital PatilSPShital Patil
- Trupti ChitreTCTrupti Chitre
- 14 July 2026
- journal article
- Published by Elsevier in Journal of the Indian Chemical Society
- Vol. 103 (9)
Abstract
No abstract availableThis publication has 71 references indexed in Scilit:
- Zaltoprofen and its novel analogues exhibit dual targeting of COX-2 and PPAR-γ, providing a strategy to alleviate lipopolysaccharide – induced acute lung injuryBiochemical Pharmacology, 2025
- Computational Design of Pyrrolo[2,1‐f]triazine‐Based Dual Wild‐Type/Mutant EGFR Inhibitors: Pharmacophore Modelling, 3D ‐ QSAR , Quantum Chemistry, and Post‐ MD Studies for Breast Cancer TherapeuticsPeptide Science, 2025
- Targeting TNBC metastasis: In-silico identification of natural origin ROCK inhibitors via virtual screening, ADMET profiling, MM-GBSA, DFT, and molecular dynamicsComputational Biology and Chemistry, 2025
- Design and synthesis of novel xanthone-thiazole hybrid derivatives as potent anti-inflammatory agentComputational Biology and Chemistry, 2025
- Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivativesBioorganic Chemistry, 2024
- Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approachesMolecular Diversity, 2024
- The Relevance of Goodness‐of‐fit, Robustness and Prediction Validation Categories of OECD‐QSAR Principles with Respect to Sample Size and Model TypeMolecular Informatics, 2022
- Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on celecoxib scaffold supported with in vivo anti-inflammatory activity, ulcerogenic liability, ADME profiling and docking studyBioorganic Chemistry, 2022
- Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 yearsActa Pharmaceutica Sinica B, 2022
- Best Practices for QSAR Model Development, Validation, and ExploitationMolecular Informatics, 2010